ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,203Medicare Part D Prescriptions Filled, Including Refills

Rank: 191 out of 682

$640K Total Retail Price of All Prescriptions

Rank: 224 out of 682

463 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 463 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

33% of this provider’s 463 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 9,398 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 924 645 S3 1 1
LEVOTHYROXINE SODIUM 634 511 2 3
LISINOPRIL 493 390 3 2
OMEPRAZOLE 318 236 4 5
NEXIUM 308 236 5 19
FUROSEMIDE 295 239 6 7
METFORMIN HCL 242 162 7 8
GABAPENTIN 231 169 8 9
AMLODIPINE BESYLATE 229 208 9 6
ZOLPIDEM TARTRATE 220 145 10 21
METOPROLOL SUCCINATE 211 169 11 16
SIMVASTATIN 196 154 12 4
METOPROLOL TARTRATE 195 152 13 10
POTASSIUM CHLORIDE 194 168 14 14
MELOXICAM 175 136 15 27
GLYBURIDE 148 96 R 16 72
ALLOPURINOL 147 104 17 32
DIOVAN 145 128 18 42
PRAVASTATIN SODIUM 140 97 19 15
CLOPIDOGREL 139 116 20 25
HYDROCHLOROTHIAZIDE 135 99 21 12
LEVOFLOXACIN 122 107 22 70
CRESTOR 122 83 22 22
ATORVASTATIN CALCIUM 116 108 24 11
PLAVIX 115 101 25 35
SERTRALINE HCL 113 105 26 24
RANITIDINE HCL 110 106 27 28
LOSARTAN POTASSIUM 109 71 28 20
AZITHROMYCIN 107 74 29 39
CARVEDILOL 102 67 30 23
WARFARIN SODIUM 100 69 31 13
TRAMADOL HCL 97 74 32 26
ESCITALOPRAM OXALATE 89 68 33 73
SINGULAIR 81 72 34 63
CYCLOBENZAPRINE HCL 81 50 R 34 65
SYNTHROID 80 41 36 59
CITALOPRAM HBR 79 58 37 17
PROAIR HFA 76 65 38 45
TAMSULOSIN HCL 75 60 39 33
LANSOPRAZOLE 69 45 40 85
ATENOLOL 68 56 41 18
CLONIDINE HCL 64 45 42 48
BENAZEPRIL HCL 63 51 43 89
SPIRIVA 62 56 44 49
DONEPEZIL HCL 62 48 44 30
PREDNISONE 62 56 44 40
AMITRIPTYLINE HCL 59 41 R 47 50
MONTELUKAST SODIUM 58 50 48 112
DIOVAN HCT 57 53 49 109
FLUTICASONE PROPIONATE 56 36 50 36
PAROXETINE HCL 55 34 51 53
PROPRANOLOL HCL 53 35 52 141
GLIPIZIDE 53 32 52 61
METHYLPREDNISOLONE 53 45 52 127
TRAZODONE HCL 52 47 55 38
ENDOCET 52 24 S2 55 88
ZETIA 52 51 55 69
CYMBALTA 52 25 55 51
DILTIAZEM 24HR CD 51 43 59 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.